Related Experiment Video
Updated: Feb 28, 2026

Visualizing Mitophagy with Fluorescent Dyes for Mitochondria and Lysosome
Published on: November 30, 2022
Modulating Mitophagy in Mitochondrial Disease
Eszter Dombi1, Heather Mortiboys2, Joanna Poulton1
1Nuffield Department of Obstetrics and Gynaecology, University of Oxford, Oxford, United Kingdom.
Mitochondrial diseases stem from genetic mutations and affect various tissues. This review explores mitophagy, a key process for clearing damaged mitochondria, and potential therapeutic drugs and supplements for these complex disorders.
Area of Science:
- Cellular Biology
- Genetics
- Neuroscience
Background:
- Mitochondrial diseases arise from mutations in mitochondrial DNA (mtDNA) or nuclear genes, leading to diverse clinical presentations.
- Mitophagy, an autophagic process, selectively removes dysfunctional mitochondria, crucial for cellular health.
- Understanding mitophagy pathways is vital for treating mitochondrial and neurodegenerative disorders.
Purpose of the Study:
- To review the mechanisms of mitophagy, distinguishing between starvation-induced (Type 1) and damage-induced (Type 2) pathways.
- To explore the role of key signaling molecules like PI3K, PINK1, and Parkin in mitophagy.
- To examine potential therapeutic interventions, including drugs and supplements, for mitochondrial diseases.
Main Methods:
- Literature review of scientific articles on mitochondrial diseases, mitophagy, and therapeutic agents.
- Analysis of signaling pathways involved in selective autophagy of mitochondria.
- Evaluation of drugs (AICAR, metformin) and supplements (Coenzyme Q, idebenone) as modulators of mitophagy.
Main Results:
- Type 1 mitophagy (starvation) relies on PI3K, while Type 2 mitophagy (damage) depends on PINK1 and Parkin.
- AMP-activated protein kinase (AMPK) signaling pathways are implicated in autophagy modulation by drugs like AICAR and metformin.
- Supplements such as Coenzyme Q and idebenone may improve mitochondrial function and rescue mitophagy in disease states.
Conclusions:
- Mitophagy is a critical cellular process with therapeutic potential for mitochondrial and neurodegenerative diseases.
- Modulators of autophagy, including specific drugs and supplements, offer promising avenues for treatment.
- Targeting mitophagy pathways could lead to novel therapeutic strategies for a range of debilitating conditions.
More Related Videos
Related Concept Videos
Translocation of Proteins into the Mitochondria
Sorting of outer membrane proteins:
Mitochondrial outer membrane proteins are of two types: the transmembrane, beta-barrel porins, and the membrane-anchored, alpha-helical proteins. Beta-barrel porin precursors are translocated by the TOM complex and inserted into the outer mitochondrial membrane by the SAM complex. In contrast,...
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
The Inner Mitochondrial Membrane
Mitochondrial Membranes
Mitochondrial Protein Sorting
Most of these mitochondrial proteins are encoded by the nucleus and imported to the mitochondria as unfolded or loosely folded precursors. Mitochondrial precursors...
Mitochondria

